InMed Pharmaceuticals Inc. buy me8
Start price
17.11.21
/
0%
€37.75
Target price
17.11.22
€50.00
Performance (%)
4.64%
End price
27.11.21
€39.50
Summary
This prediction ended on 27.11.21 with a price of €39.50. The BUY prediction by me8 finished with a performance of 4.64%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
InMed Pharmaceuticals Inc. | 154.344% | 154.344% | -56.309% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
According to me8 what are the pros and cons of InMed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Cons
Little innovation
Comments by me8 for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Buy InMed Pharmaceuticals Inc.
Kursziel gesetzt auf 2,0
In the thread Trading InMed Pharmaceuticals Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by me8 for InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.30
20.03.23
20.03.23
-
20.03.24
20.03.24
6.18%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation